Scott Martin Vouri
Overview
Explore the profile of Scott Martin Vouri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reise R, Usmani S, Morris E, Ndai A, Dewar M, Vouri S
Am J Health Syst Pharm
. 2025 Jan;
PMID: 39756415
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are...
2.
Reise R, Ndai A, Dewar M, Schentrup A, Yang J, Vouri S
Explor Res Clin Soc Pharm
. 2024 Jul;
14:100460.
PMID: 38974055
Background: This study evaluates the impact of Real-Time Prescription Benefits (RTPB), a tool integrated into electronic health records (EHRs), on patient out-of-pocket costs in an academic institution. RTPB provides prescribers...
3.
Ndai A, Al Bahou J, Morris E, Wang H, Marcum Z, Hung A, et al.
J Am Geriatr Soc
. 2023 Dec;
72(1):126-138.
PMID: 38124261
Background: Potentially inappropriate medications (PIMs) in older adults are medications in which risks often outweigh benefits and are suggested to be avoided. Worldwide, many distinct guidelines and tools classify PIMs...
4.
Wang G, Svensson M, Shao H, Vouri S, Park H
J Manag Care Spec Pharm
. 2023 Jul;
29(8):884-895.
PMID: 37523313
Paliperidone is among the most cost-effective antipsychotics in adults with schizophrenia, and it has different formulations, including oral paliperidone extended-release (ER) and long-acting injectable (LAI) paliperidone formulations administered every month...
5.
Jiang X, Diaby V, Vouri S, Lo-Ciganic W, Parker R, Wang W, et al.
Am J Prev Med
. 2022 Oct;
64(1):96-104.
PMID: 36257884
Introduction: The objective of this study was to estimate the economic impact of providing universal hepatitis C virus testing in commercially insured middle-aged persons who inject drugs in the U.S....
6.
Vouri S, Morris E, Wang G, Hashim Jaber Bilal A, Hallas J, Henriksen D
Br J Clin Pharmacol
. 2022 Jun;
88(12):5269-5294.
PMID: 35748326
Aims: To assess the gabapentinoid-oedema-loop diuretic prescribing cascade in adults using large administrative health care databases from the USA and Denmark. Methods: This study used a sequence symmetry analysis to...
7.
Al-Bahou J, Bhagwandass H, Valdes I, Friedman J, Vouri S
World J Urol
. 2022 Apr;
40(7):1777-1783.
PMID: 35384485
Purpose: Bariatric surgery has shown reductions in overactive bladder (OAB) symptoms; however, the impacts on OAB treatment is unknown. The goal of our study is to evaluate the impact of...
8.
Vouri S, Morris E, Jiang X, Hofer A, Schmidt S, Pepine C, et al.
Am J Hypertens
. 2022 Feb;
35(7):601-609.
PMID: 35106529
Background: Drug-related adverse events associated with antihypertensive therapy may result in subsequent prescribing of other potentially harmful medications, known as prescribing cascades. The aim of this study was to assess...
9.
Oueini R, Goodin A, Hincapie-Castillo J, Vouri S
J Am Pharm Assoc (2003)
. 2021 Nov;
62(2):468-474.e2.
PMID: 34799261
Objective(s): This study aimed to characterize the co-utilization of non-benzodiazepine sedative 'Z'-drugs with opioids at ambulatory care visits in the United States. Design: A cross-sectional analysis of the National Ambulatory...
10.
Jiang X, Vouri S, Diaby V, Lo-Ciganic W, Parker R, Park H
J Manag Care Spec Pharm
. 2021 Oct;
27(10):1388-1402.
PMID: 34595949
Patients with substance use disorders (SUD) and chronic hepatitis C virus infection (HCV) have limited access to direct-acting antivirals (DAAs) due to multilevel issues related to providers (eg, concern about...